Publications

5808 Results

Allelic loss during progression of follicular lymphoma

Authors
S Takeuchi;S de Vos;N Takeuchi;AC Fermin;TM Grogan;H Seo;JW Said;HP Koeffler
Journal / Conference
Leukemia Research 28:567-569
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL).

Authors
JA Sloan;H McLeod;D Sargent;X Zhao;C. Goldberg
Journal / Conference
Proc of the American Society of Clinical Oncology 23:2 (#5)
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
N9741

Prognostic factors in early stage head and neck squamous cell carcinoma (HNSCC) patients in a prospective clinical trial

Authors
ES Kim;J Lee;L Feng;S Lippman;G Shenouda;I Hodson;E Vokes;F Khuri;WK Hong
Journal / Conference
Proc of the American Society of Clinical Oncology 23:490 (#5515)
Year
2004
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9446

Rethinking the use of chemotherapy and radiation after radical hysterectomy: a clinical-pathologic analysis of SWOG 8797/GOG 109

Authors
SS Im;BJ Monk;J Wang;RJ Stock;WA Peters III;PY Liu;RJ Barrett;JS Berek;L Souhami;P Grisby;W Gordon;DS Alberts
Journal / Conference
Gynecologic Oncology 92:396 (#8)
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)

Histologic subtypes do not confer unique outcomes in early-stage lymphoma: long-term follow-up of SWOG 8736

Authors
CM Spier;M LeBlanc;EM Chase;RI Fisher;TP Miller
Journal / Conference
Blood 104(11): #3263
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8736 (INT-0093)

HLA-DR protein status predicts survival in patients with diffuse large B cell lymphoma (DLBCL) treated with the MACOP-B chemotherapy regimen

Authors
LM Rimsza;P Farinha;DA Fuchs;H Masoudi;JM Connors;RD Gascoyne
Journal / Conference
Blood 104(11): #3273
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

FC receptor polymorphisms do not influence progression free survival (PFS) of follicular NHL patients treated with CHOP followed by rituximab (SWOG 9800)

Authors
DG Maloney;B Pender-Smith;JM Unger;RM Braziel;J Radich;OW Press;TP Miller;TM Grogan;M LeBlanc;RI Fisher
Journal / Conference
Blood 104(11): #589
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
S9800

Gene expression profiling, frozen and paraffin section immunohistochemistry, and in situ hybridization for determination of monoclonality in diffuse large B-cell lymphoma

Authors
MW Andres;RA Roberts;DJ Mustacich;RD Gascoyne;DA Fuchs;MX Wang;RM Braziel;WC Chan;TM Grogan;LM Rimsza
Journal / Conference
Blood 104(11): #4553
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Introducing HIPPAA: triple the cost and triple and time for patient recruitment to the SELECT study

Authors
NS Gorby;MS Wolf;CL Bennett
Journal / Conference
Proc of the American Society of Clinical Oncology 23:519 (#6009)
Year
2004
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Acute myeloid leukemia (AML) with t(6;9)(p23;q34) defines a very poor risk leukemia subgroup with distinguishing clinicopathological features: a United States (US) cytogenetics Intergroup study of 62 AML and MDS cases.

Authors
ML Slovak;CD Bloomfield;H Gundacker;G Dewald;FR Appelbaum;RA Larson;MS Tallman;C Willman;Y Ravindranath;TA Alonzo;A Carroll;B Hirsch;S Raimondi;NA Heerema
Journal / Conference
Blood 104(11): #567
Year
2004
Research Committee(s)
Leukemia